Graph’s logo combines a giraffe-inspired design with digital circuit elements to represent technology and innovation.
Pharmaceutical-sector focused artificial intelligence startup Graph AI secures $13.3 Mn to scale its operations globally.
Pharmaceutical-sector focused artificial intelligence startup Graph AI has raised $13.3 Mn, approximately ₹127.2 Cr, to accelerate its international expansion. 1 The fresh capital injection will be deployed to support the company’s growth initiatives and scale its technological footprint across global pharmaceutical markets.
Graph AI operates at the intersection of advanced technology and drug development, building specialized AI solutions tailored specifically for the pharmaceutical sector. The startup focuses on addressing complex data and analytical challenges inherent in modern medicine discovery and pharma operations.
The pharmaceutical industry faces persistent hurdles in data processing, research efficiency, and operational speed, areas where traditional software solutions often fall short. Graph AI addresses this market gap by deploying machine learning and advanced data models designed to streamline workflows within the sector.
The newly secured funds will be channeled directly into international expansion efforts, allowing the company to introduce its proprietary technology to a broader base of global clients.
As artificial intelligence continues to reshape traditional industries, startups like Graph AI are well-positioned to capture growing enterprise demand for sector-specific technological transformation.
